Figure 5 BMI and cardiorespiratory fitness levels

Slides:

Advertisements

Similar presentations

A GRADUATING RESEARCH PROJECT FOR THE BACHALOLIC DEGEES.

Advertisements

Nat. Rev. Cardiol. doi: /nrcardio

Copyright © 2017 American Academy of Pediatrics.

Nat. Rev. Cardiol. doi: /nrcardio

Figure 10 Assessment of myocardial fibrosis

Reproduced with permission from Yancy, C. W. et al. 2017

Figure 8 Implanted devices for the management of heart failure

Nat. Rev. Cardiol. doi: /nrcardio

Figure 4 BMI and mortality in patients with heart failure

Nat. Rev. Cardiol. doi: /nrcardio

Figure 5 Two approaches to therapeutic genome editing

Nat. Rev. Cardiol. doi: /nrcardio

Figure 2 Pathological specimens showing the most common reasons for bioprosthetic valve failure Figure 2 | Pathological specimens showing the most common.

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 Global rates of sodium, fruit, and vegetable intake

Kaplan-Meier survival curves comparing survival between both time periods according to management strategy. Survival in patients with infective endocarditis.

Figure 2 Size categorization of airborne pollutants

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 2 Three-year survival rates on the basis of body composition

Figure 2 Physical activity and obesity levels by WHO-designated region and sex Figure 2 | Physical activity and obesity levels by WHO-designated region.

Figure 8 4D magnetic resonance imaging patterns

Figure 4 Effects of delaying cardioprotective medications after anthracycline administration Figure 4 | Effects of delaying cardioprotective medications.

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Obesity and Heart Failure: Focus on the Obesity Paradox

Nat. Rev. Cardiol. doi: /nrcardio

Figure 6 Pharmacodynamic profile of switching between clopidogrel and ticagrelor therapy: results from the RESPOND study Figure 6| Pharmacodynamic profile.

Figure 4 Prevalence of HFpEF and HFrEF by age

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 Health-care system today

Body Composition and Heart Failure Prevalence and Prognosis: Getting to the Fat of the Matter in the “Obesity Paradox” Carl J. Lavie, MD, Richard V.

Figure 1 Cardiovascular risk and disease across the life-course

Figure 1 Decision tree integrating the assessment,

Figure 3 Neural crest cell migration

Figure 2 Global cost of HF per capita in 2012

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Endocrinol. doi: /nrendo

Figure 3 Challenges for big data applications in cardiovascular care

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 Effects of cardiovascular medication on the fetus

Nat. Rev. Cardiol. doi: /nrcardio

Figure 4 Observational studies on multiple treatment strategies

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 U‑shape relationship between exercise dose and risk of atrial fibrillation (AF) Figure 3 | U-shape relationship between exercise dose and risk.

Figure 6 The neurogenic components of angina

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 2 Impaired mitochondrial capacity and function in heart failure

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

(A) Kaplan-Meier curve showing AF-free survival after a single procedure for patients grouped according to use of CT integration. (A) Kaplan-Meier curve.

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

(A) Mortality in patients with heart failure and different estimated glomerular filtration rate (eGFR) strata, crude survival assessed by Kaplan-Meier.

Kaplan-Meier survival estimates for major cardiovascular events.

Kaplan-Meier curves for the end point all-cause mortality in the total patient population stratified according to complete/incomplete revascularisation.

Kaplan-Meier survival analysis for all-cause and CVD mortality in 2,823 type 2 diabetic patients stratified by CKD according to each creatinine-based equation.

Kaplan-Meier estimate of mortality in the two treatment strategies with significant difference between the two groups (log-rank test

Predictive Validity of a Medical-Related Cardiorespiratory Fitness Algorithm in Predicting Cardiovascular Disease– and All-Cause Mortality: Implications.

Presentation transcript:

Figure 5 BMI and cardiorespiratory fitness levels Figure 5 | BMI and cardiorespiratory fitness levels. Kaplan-Meier analyses according to BMI with the a | low cardiorespiratory fitness (CRF) group (O2 consumption <14 mLO2 kg−1 min−1, log rank 11.7, P = 0.003) and b | high CRF group (O2 consumption ≥14 mLO2 kg−1 min−1, log rank 1.72, P = 0.42). BMI is expressed as kg/m2. Reproduced from Lavie, C. J. et al. Impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure. Mayo Clin. Proc. 88, 251–258 (2013), with permission from Elsevier. Reproduced from Lavie, C. J. et al. Impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure. Mayo Clin. Proc. 88, 251–258 (2013), with permission from Elsevier Lavie, C. J. et al. (2017) Management of cardiovascular diseases in patients with obesity Nat. Rev. Cardiol. doi:10.1038/nrcardio.2017.108